NCT02733224|UnknownDMC
Loading search results
Sponsor study identifier
observational
80
0 countries
N/A
Study Start
June 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
we intend to evaluate the association between non-adherence to Lenalidomide in Multiple Myeloma (MM) patients and overall response rates and time to progression (TTP). Adherence will be measured in several ways, including by electronic monitoring, which is the gold standard method.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 5, 2016
Actual (reported)April 11, 2016
Actual (reported)June 2016
Date type not reportedThis date has not been verified as actual or estimated.
March 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Response to treatment (Overall response) 4 weeks after finishing five months of electronic adherence monitoring (i.e. at 6 months).
within 4 weeks after 5 months of follow-up
Patients diagnosed with active MM starting induction treatment with the lenalidomide with or without dexamethasone, as any line of therapy.
First Submitted
April 5, 2016
First Posted
April 11, 2016
Study Start
June 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2017
Estimated (date passed)Telehealth Intervention for Improved Blood Pressure Control With Targeted Incentives
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
June 3, 2016
Record last verified: 2016-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: